Guangzhou Baiy reported CNY1.85B in Selling and Administration Expenses for its fiscal quarter ending in June of 2026.





Selling And Administration Expenses Change Date
Aspen Pharmacare ZAR 4.35B 1.28B Dec/2025
Cipla INR 13.25B 101.8M Dec/2025
Dr.Reddys Laboratories INR 26.1B 11.63B Jun/2026
Jiangsu Hengrui CNY 2.93B 143.13M Sep/2026
Kalbe Farma IDR 1.34T 1.17T Mar/2026
Richter Gedeon HUF 55.32B 3.03B Mar/2026
Sh Fosun Pharma CNY 3.07B 276.55M Sep/2026
Sh Pharmaceutical CNY 4.69B 96.06M Jun/2026
Sun Pharmaceuticals INR 24.89B 637.6M Mar/2025
Teva Pharmaceutical Industries USD 1.03B 34M Jun/2026